WallStSmart
SLS

Sellas Life Sciences Group Inc

NASDAQ: SLS · HEALTHCARE · BIOTECHNOLOGY

$4.95
+6.00% today

Updated 2026-04-30

Market cap
$900.52M
P/E ratio
P/S ratio
26.90x
EPS (TTM)
$-0.25
Dividend yield
52W range
$1 – $6
Volume
6.7M

Sellas Life Sciences Group Inc (SLS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-2.11M$-6.05M$-9.43M$-11.77M$-10.26M$-14.67M$-20.96M$-28.91M$-42.87M$-48.16M$-44.91M$-10.99M$-30.42M$-17.64M$-10.42M$-26.02M$-23.81M$-31.41M$-35.40M$-28.39M
Capital expenditures$0.00$229000.00$166000.00$83000.00$106000.00$53000.00$739000.00$15.85M$5.53M$153000.00$6000.00$0.00$0.00$0.00$0.00$0.00$4.50M$5.50M$0.00$0.00
Depreciation
Stock-based comp$3.82M$4.20M$4.37M$3.00M$1.39M$2.53M$5.39M$1.93M$2.26M$3.17M$395000.00$573000.00$578000.00$1.01M$1.73M$1.39M$1.56M$1.96M
Free cash flow$-2.11M$-6.28M$-9.60M$-11.85M$-10.36M$-14.72M$-21.70M$-44.76M$-48.40M$-48.31M$-44.92M$-10.99M$-30.42M$-17.64M$-10.42M$-26.02M$-28.31M$-36.91M$-35.40M$-28.39M
Investing cash flow
Financing cash flow
Dividends paid$464000.00$0.00$0.00$0.00$0.00$487000.00$487000.00$675000.00$487000.00$0.00
Share repurchases
Debt repayment
Net change in cash$4.54M$21.37M$14.98M$-24.14M$6.08M$-11.65M$-3.64M$-7.30M$1.93M$28.02M